KRYS - Krystal Biotech Q3 2023 Earnings Preview
2023-11-03 11:34:51 ET
More on Krystal Biotech
- Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement
- Cantor starts Krystal Biotech at overweight, cites Vyjuvek launch
- Krystal Biotech wins FDA nod to run trial for gene therapy
- Seeking Alpha’s Quant Rating on Krystal Biotech
- Historical earnings data for Krystal Biotech
For further details see:
Krystal Biotech Q3 2023 Earnings Preview